The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
Antineoplastic Combined Chemotherapy Protocols
Dose-dense AC followed by P/T followed by T is feasible and is not likely to increase the incidence of cardiac events compared to established regimens.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency